Among the cancers present in the FMI database, ERBB-KDD was found most frequently in glioma (2.4%, 227/9381 total glioma cases), followed by upper gastrointestinal cancer (upper GI; 0.8%, 89/11,822) and non-small cell lung cancer (NSCLC; 0.2%, 109/48,699). Here, EGFR is linked to glioma.